S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.

about

Lauren classification and individualized chemotherapy in gastric cancer.

P2860

Q36824887-20B5C667-064F-492B-A708-16447557A4E9

P2860

S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.

Item

http://www.wikidata.org/entity/Q42263964

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

S-1 plus intravenous and intra ...... er with peritoneal metastasis.

@en

S-1 plus intravenous and intra ...... er with peritoneal metastasis.

@nl

type

Item

label

S-1 plus intravenous and intra ...... er with peritoneal metastasis.

@en

S-1 plus intravenous and intra ...... er with peritoneal metastasis.

@nl

prefLabel

S-1 plus intravenous and intra ...... er with peritoneal metastasis.

@en

S-1 plus intravenous and intra ...... er with peritoneal metastasis.

@nl

P1476

S-1 plus intravenous and intra ...... er with peritoneal metastasis.

@en

P2093

Hironori Ishigami

http://www.w3.org/2001/XMLSchema#string

Hironori Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Joji Kitayama

http://www.w3.org/2001/XMLSchema#string

Shigenobu Emoto

http://www.w3.org/2001/XMLSchema#string

Shoichi Kaisaki

http://www.w3.org/2001/XMLSchema#string

P2860

Disparities in gastric cancer chemotherapy between the East and West.

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.

Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination.

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions.

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.

Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer.

Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

P304

S10-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroharu Yamashita

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22876333

http://www.w3.org/2001/XMLSchema#string

P932

3413026

http://www.w3.org/2001/XMLSchema#string

S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.

about

P2860

P2860

S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932